University Hospital Vall d'Hebron, Barcelona (Spain)
Follow
Contributor content
Presentation
Use and outcomes of triple antithrombotic therapy with vitamin K antagonists versus non-vitamin K antagonists in patients with atrial fibrillation undergoing percutaneous coronary intervention
